APA (7th ed.) Citation

Zeng, Q., Zhou, Z., Zhang, J., Cai, R., Yang, H., Chen, P., & Li, L. A new prognostic model for predicting overall survival and progression-free survival in unresectable hepatocellular carcinoma treated with the FOLFOX-HAIC regimen based on patient clinical characteristics and blood biomarkers. BMC.

Chicago Style (17th ed.) Citation

Zeng, Qiuyao, Zehong Zhou, Ji Zhang, Rongzeng Cai, Hongwei Yang, Pengfei Chen, and Linfang Li. A New Prognostic Model for Predicting Overall Survival and Progression-free Survival in Unresectable Hepatocellular Carcinoma Treated with the FOLFOX-HAIC Regimen Based on Patient Clinical Characteristics and Blood Biomarkers. BMC.

MLA (9th ed.) Citation

Zeng, Qiuyao, et al. A New Prognostic Model for Predicting Overall Survival and Progression-free Survival in Unresectable Hepatocellular Carcinoma Treated with the FOLFOX-HAIC Regimen Based on Patient Clinical Characteristics and Blood Biomarkers. BMC.